Nucleic Acid Amplification Testing (NAAT) Market Share

Statistics for the 2023 & 2024 Nucleic Acid Amplification Testing (NAAT) market share, created by Mordor Intelligence™ Industry Reports. Nucleic Acid Amplification Testing (NAAT) share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Nucleic Acid Amplification Testing (NAAT) Industry

The nucleic acid amplification testing (NAAT) market is moderately fragmented. The factors owing to the competition include rising infectious diseases, the rising launch of products, and rising partnerships between key players, among others. Some of the market players are Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc., Grifols SA, Hoffmann-La Roche Ltd., Hologic Inc., and Illumina Inc

Nucleic Acid Amplification Testing Market Leaders

  1. bioMérieux SA

  2. Hoffmann-La Roche Ltd

  3. Abbott Laboratories

  4. Bio-Rad Laboratories, Inc.

  5. Grifols SA

*Disclaimer: Major Players sorted in no particular order

Nucleic Acid Amplification Testing Market Concentration

Nucleic Acid Amplification Testing (NAAT) Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)